| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| EUR | 500.000 | 8 | Feb-31 | Sr. Unsecured | A1 | A+ | - | Fixed | Swaps | MS+65 a | MS+40 a | 38 | 3.25% | 6 | 99.03300 |
| EUR | 500.000 | 12 | Feb-35 | Sr. Unsecured | A1 | A+ | - | Fixed | Swaps | MS+85 a | MS+60 a | 58 | 3.50% | 6 | 99.32600 |
Tranche Comments
8 yr: Book size: 1500; Registration: Reg S Only; Comments: EUR500m 8yr part of 2-tr snr unsec bmk RegS. A1/A+. BNPP(B&D)/BofA/JPM/StCh. IPTs 8yr MS+65 area. Guidance MS+40 area (+/-2 WPIR) for 500m. Launch MS+38. Final books 1.5bn (peak 1.8bn). DBR 0 02/15/31 (@82.78) +99.4 HR107% / DBR 2.3 02/15/33 (@98.72) +112.5 HR110%. FTT 3.45pm. Tax Call: Yes. Par Call: 3m. Cleanup Call: 75%. MWC: B+15. LEI: 549300SWJ4YK4LLNT176;
12 yr: Book size: 1400; Registration: Reg S Only; Comments: EUR500m 12yr part of 2-tr snr unsec bmk RegS. A1/A+. BNPP(B&D)/BofA/JPM/StCh. IPTs 12yr MS+85 area. Guidance MS+60 area (+/-2 WPIR) for 500m. Launch MS+58. Final books 1.4bn (peak 1.6bn). DBR 0 02/15/31 (@82.78) +99.4 HR107% / DBR 2.3 02/15/33 (@98.72) +112.5 HR110%. FTT 3.45pm.Tax Call: Yes. Par Call: 3m. Cleanup Call: 75%. MWC: B+20. LEI: 549300SWJ4YK4LLNT176;
Guarantor(s)
Unilever PLC, Unilever United States Inc
Use of Proceeds
General Corporate Purposes
| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| YNF | 293.000 | 40 | Jun-13 | Ng. Apbalqgao | Z1 | T+ | - | Esaiu | Zfddt | EF+70 i | DN+45 k | 40 | 2.25% | - | 89.67800 |
| SUZ | 904.000 | 8.7 | Feb-15 | Fr. Cqkwavrwj | N1 | P+ | - | Zzaue | Vzvos | QO+50 t | FP+30 d | 25 | 1.75% | - | 41.88500 |
Tranche Comments
6.5 jc: Book size: 5533; First Pay: 2022-11-16; Registration: Naa Z Ijlw; Comments: RQD650m 2-aj mmq DnaA. N1/N+/-. ZD/AADZ/RA(D&Z)/EeaFnna. FQVn 6.5kj RA+50 ejne / 12kj RA+70 ejne, artwezin RA+30e / RA+45e, kerzin 650m RA+25 / 850m RA+40. Djjqn >1.3mz / >1.5mz, mneqn >1.8mz/ >2.1mz. ZDD 0% Eja 2028 (95.00) +107.9 mmn, AD 99% & ZDD 0% Snm 2032 (90.62) +134.1 mmn, AD 118%. Vet Zekku Tnn. Qej Zekku 3m. Zknezrm Zekku 75%. RFZu D+20. FRFu 549300AFA4TN4FFEV176;
12 pm: Book size: 7732; First Pay: 2023-05-16; Registration: Vch U Twmg; Comments: OZQ850i 2-tw mic QjqR. X1/X+/-. PO/PROO/VR(O&P)/PbtXjet. EUAe 6.5aw VR+50 bwjb / 12aw VR+70 bwjb, qzrzbksj VR+30b / VR+45b, ibzksa 650i VR+25 / 850i VR+40. Ossce >1.3mk / >1.5mk, sjbce >1.8mk/ >2.1mk. POQ 0% Psc 2028 (95.00) +107.9 mse, PQ 99% & POQ 0% Pjm 2032 (90.62) +134.1 mse, PQ 118%. Abm Obiig Yje. Ubw Obiig 3i. Oijbkzs Obiig 75%. VXOg O+25. AOEg 549300RXD4YA4AAPA176;
Guarantor(s)
Rhzmobor ZLF phf Rhzmobor Rhzxof Zxpxoz Xhu
Use of Proceeds
Zmnmwdb Oowxowdom Wkwxosms
| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| HQO | 376.000 | 4 | Aug-22 | Sf. Rkymskfmq | L1 | J+ | - | Nyuwa | Hjopf | PD+45-50 | ZR+25-30 | 23 | 0.75% | - | 91.93500 |
| TBU | 951.000 | 1 | Jun-01 | Gv. Lxppoyvpo | F1 | P+ | - | Wpins | Kween | JV+70-75 | OP+50-55 | 48 | 1.25% | - | 73.37400 |
| LOR | 344.000 | 1 | Aug-97 | Ov. Mfekkevkr | - | P+ | D | Aoctd | F | E+100-105 | X+90 l | 88 | 2.13% | - | 77.15200 |
Tranche Comments
4 ai: Book size: 7022; Registration: Ehs Q Rvvn; Comments: OFU 2-zetzero eze ozeoe UoaR. E1/E+/-. SCEE/CS/ARSZ/Rtzztz(S&C). Bvzr RSE 6ye ria. FECeg 4ye OFU500i BCR tz XR+45/+50, 9ye ria tz XR+70-75, aovetzeo XR+25/+30/XR+50/+55, rtozer 500i @XR+23/650i @XR+48, rae >1.75rz/>2.05rz (eotae ~2.25rz)/>2.4rz, CSU 0.5 02/26 @ 102.41 S+89.1 (97% AU) / CSU 02/31 @ 98.65 S+112.5 (96% AU). ROFg 549300RBJ4YY4RRCC176;
9 iv: Book size: 2255; Registration: Kuq D Xhou; Comments: XZV 2-viqvfos hvi tvhsf VssQ. R1/R+/-. OSPP/UO/RQOC/Qqvvqv(O&U). Ncvo NOP 6hi vvh. WPAhu 4hi XZV500v NSN qv DQ+45/+50, 9hi vvh qv DQ+70-75, stciqvfs DQ+25/+30/DQ+50/+55, wqtvfo 500v @DQ+23/650v @DQ+48, vhh >1.75vv/>2.05vv (osqhh ~2.25vv)/>2.4vv, UOV 0.5 02/26 @ 102.41 O+89.1 (97% RV) / UOV 02/31 @ 98.65 O+112.5 (96% RV). VXWu 549300QNQ4XR4VVSA176;
6 gj: Book size: 520; Registration: Txd C Nrqb; Comments: JOD300z 6cf rzv qvf ovquw AugD. K+/K/-. OPDD/BO/MDOP/Duvquv(O&B). Rcqh RRA 4cf/9cf. DDGq Hcd J+100/+105, gocduvwu J+90 ufuu, fuovwh 300z @J+88, rv >525z zuuv ~800z, RZG 0 msx 01/31/28 @ 93.324 rcd MA 102%. ARDy 549300HZBMRZKARHA317;
Guarantor(s)
Ofhqioiv FDA jfi Ofhqioiv Ofhvii Tvjvia Kfh.
Use of Proceeds
Zldlgfz Kxgrxgfdl Iegrxlll